ロード中...

Nifedipine protects against overproduction of superoxide anion by monocytes from patients with systemic sclerosis

We have reported previously that dihydropyridine-type calcium-channel antagonists (DTCCA) such as nifedipine decrease plasma markers of oxidative stress damage in systemic sclerosis (SSc). To clarify the cellular basis of these beneficial effects, we investigated the effects in vivo and in vitro of...

詳細記述

保存先:
書誌詳細
主要な著者: Allanore, Yannick, Borderie, Didier, Périanin, Axel, Lemaréchal, Hervé, Ekindjian, Ohvanesse Garabed, Kahan, André
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2005
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC1064885/
https://ncbi.nlm.nih.gov/pubmed/15642147
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar1457
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!